By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ReVance Therapeutics, Inc. 

2400 Bayshore Parkway, Suite 100

Mountain View  California  94043  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
ReVance Therapeutics, Inc. (RVNC) Defines Clinical Program Milestones And Provides Financial Guidance For 2015 1/12/2015 7:24:52 AM
ReVance Therapeutics, Inc. (RVNC) Announces Publication of Positive Results From RT002 Phase 1/2 Study 1/9/2015 7:24:35 AM
ReVance Therapeutics, Inc. (RVNC) Announces Initiation Of BELMONT Phase 2 Active Comparator Trial Of Injectable RT002 1/5/2015 7:01:31 AM
ReVance Therapeutics, Inc. (RVNC) Announces Participation In 26th Annual Piper Jaffray Healthcare Conference 11/21/2014 12:37:48 PM
ReVance Therapeutics, Inc. (RVNC) Releases Third Quarter 2014 Results 11/13/2014 9:14:06 AM
ReVance Therapeutics, Inc. (RVNC) Announces Participation In Credit Suisse 2014 Healthcare Conference 11/5/2014 10:09:42 AM
ReVance Therapeutics, Inc. (RVNC) To Release Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, November 12, 2014 10/30/2014 8:01:14 AM
ReVance Therapeutics, Inc. (RVNC) Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Feet Lines 10/2/2014 7:50:29 AM
ReVance Therapeutics, Inc. (RVNC) Announces The Appointment Of Azita Nejad As Vice President Of Quality 9/23/2014 7:38:53 AM
ReVance Therapeutics, Inc. (RVNC) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/3/2014 7:20:37 AM
1234
//-->